Correlation Between Rafarma Pharmaceuticals and Pressure Biosciences

Can any of the company-specific risk be diversified away by investing in both Rafarma Pharmaceuticals and Pressure Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rafarma Pharmaceuticals and Pressure Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rafarma Pharmaceuticals and Pressure Biosciences, you can compare the effects of market volatilities on Rafarma Pharmaceuticals and Pressure Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rafarma Pharmaceuticals with a short position of Pressure Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rafarma Pharmaceuticals and Pressure Biosciences.

Diversification Opportunities for Rafarma Pharmaceuticals and Pressure Biosciences

0.0

Correlation Coefficient

Rafarma Pharmaceuticals  Pressure Biosciences

Pay attention - limited upside

The 3 months correlation between Rafarma and Pressure is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Rafarma Pharmaceuticals and Pressure Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pressure Biosciences and Rafarma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rafarma Pharmaceuticals are associated (or correlated) with Pressure Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pressure Biosciences has no effect on the direction of Rafarma Pharmaceuticals i.e., Rafarma Pharmaceuticals and Pressure Biosciences go up and down completely randomly.

Pair Corralation between Rafarma Pharmaceuticals and Pressure Biosciences

If you would invest  8.20  in Rafarma Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of  6.80  from holding Rafarma Pharmaceuticals or generate 82.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Rafarma Pharmaceuticals  vs.  Pressure Biosciences

Rafarma Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rafarma Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent technical and fundamental indicators, Rafarma Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pressure Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pressure Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Pressure Biosciences is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Rafarma Pharmaceuticals and Pressure Biosciences

The main advantage of trading using opposite Rafarma Pharmaceuticals and Pressure Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rafarma Pharmaceuticals position performs unexpectedly, Pressure Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will offset losses from the drop in Pressure Biosciences' long position.

The idea behind Rafarma Pharmaceuticals and Pressure Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.